Advertisement

Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in patients with optic neuritis and seizures

Published:February 03, 2018DOI:https://doi.org/10.1016/j.jns.2018.01.042

      Highlights

      • Four patients with optic neuritis and seizure were MOG antibody seropositive.
      • Episodes of seizure and optic neuritis were separated by up to ten years.
      • Seizures occurred either in the setting of ADEM or during steroid taper.
      • Seizure in a patient with prior optic neuritis should prompt MOG antibody testing.

      Abstract

      We describe four patients who experienced optic neuritis (ON) and seizures and were found to have antibodies to myelin oligodendrocyte glycoprotein (MOG) in serum. The index case was a previously healthy 39-year-old man who developed steroid dependent ON and had a generalized seizure when steroids were tapered. He tested positive for antibodies to MOG. We have reviewed the charts of all 11 anti-MOG antibody positive patients in our practice and found that 4 patients, all of whom had experienced one or more episodes of ON, also had a generalized seizure during the course of their illness. In 2 patients – including the index case - seizure occurred during steroid taper and in 2 others at the time of an episode of acute disseminated encephalomyelitis (ADEM). Association of anti-MOG antibodies and relapsing demyelinating disorders of the central nervous system is increasingly recognized. Testing for anti-MOG antibodies should be considered in patients with optic neuritis and seizures, especially in those with who also have a history of ADEM.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Ramanathan S.
        • Dale R.C.
        • Brilot F.
        Anti-MOG antibody: the history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination.
        Autoimmun. Rev. 2016; 15: 307-324https://doi.org/10.1016/j.autrev.2015.12.004
        • Baumann M.
        • Sahin K.
        • Lechner C.
        • Hennes E.M.
        • Schanda K.
        • Mader S.
        • Karenfort M.
        • Selch C.
        • Häusler M.
        • Eisenkölbl A.
        • Salandin M.
        • Gruber-Sedlmayr U.
        • Blaschek A.
        • Kraus V.
        • Leiz S.
        • Finsterwalder J.
        • Gotwald T.
        • Kuchukhidze G.
        • Berger T.
        • Reindl M.
        • Rostásy K.
        Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein.
        J. Neurol. Neurosurg. Psychiatry. 2015; 86: 265-272https://doi.org/10.1136/jnnp-2014-308346
        • Hacohen Y.
        • Mankad K.
        • Chong W.K.
        • Barkhof F.
        • Vincent A.
        • Lim M.
        • Wassmer E.
        • Ciccarelli O.
        • Hemingway C.
        Diagnostic algorithm for relapsing acquired demyelinating syndromes in children.
        Neurology. 2017; 89: 269-278https://doi.org/10.1212/WNL.0000000000004117
        • Chalmoukou K.
        • Alexopoulos H.
        • Akrivou S.
        • Stathopoulos P.
        • Reindl M.
        • Dalakas M.C.
        Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis.
        Neurol. Neuroimmunol. Neuroinflammation. 2015; 2https://doi.org/10.1212/NXI.0000000000000131
        • Jarius S.
        • Ruprecht K.
        • Kleiter I.
        • Borisow N.
        • Asgari N.
        • Pitarokoili K.
        • Pache F.
        • Stich O.
        • Beume L.-A.
        • Hümmert M.W.
        • Ringelstein M.
        • Trebst C.
        • Winkelmann A.
        • Schwarz A.
        • Buttmann M.
        • Zimmermann H.
        • Kuchling J.
        • Franciotta D.
        • Capobianco M.
        • Siebert E.
        • Lukas C.
        • Korporal-Kuhnke M.
        • Haas J.
        • Fechner K.
        • Brandt A.U.
        • Schanda K.
        • Aktas O.
        • Paul F.
        • Reindl M.
        • Wildemann B.
        In cooperation with the N.O.S.G. (nemos), MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
        J. Neuroinflammation. 2016; 13: 280https://doi.org/10.1186/s12974-016-0718-0
        • Ogawa R.
        • Nakashima I.
        • Takahashi T.
        • Kaneko K.
        • Akaishi T.
        • Takai Y.
        • Sato D.K.
        • Nishiyama S.
        • Misu T.
        • Kuroda H.
        • Aoki M.
        • Fujihara K.
        MOG antibody–positive, benign, unilateral, cerebral cortical encephalitis with epilepsy.
        Neurol. Neuroimmunol. Neuroinflammation. 2017; 4e322https://doi.org/10.1212/NXI.0000000000000322
        • Hamid S.H.M.
        • Whittam D.
        • Saviour M.
        • Alorainy A.
        • Mutch K.
        • Linaker S.
        • Solomon T.
        • Bhojak M.
        • Woodhall M.
        • Waters P.
        • Appleton R.
        • Duddy M.
        • Jacob A.
        Seizures and encephalitis in myelin oligodendrocyte glycoprotein IgG disease vs aquaporin 4 IgG disease.
        JAMA Neurol. 2017; https://doi.org/10.1001/jamaneurol.2017.3196
        • Gutman J.M.
        • Levy M.
        • Galetta S.
        • Kister I.
        Clinical reasoning: a patient with a history of encephalomyelitis and recurrent optic neuritis.
        Neurology. 2017; 89: e231-e234https://doi.org/10.1212/WNL.0000000000004628
        • Tsuburaya R.S.
        • Miki N.
        • Tanaka K.
        • Kageyama T.
        • Irahara K.
        • Mukaida S.
        • Shiraishi K.
        • Tanaka M.
        Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in a Japanese boy with recurrent optic neuritis.
        Brain and Development. 2015; 37: 145-148https://doi.org/10.1016/j.braindev.2014.02.002
        • Kidd D.
        • Burton B.
        • Plant G.T.
        • Graham E.M.
        Chronic relapsing inflammatory optic neuropathy (CRION).
        Brain. 2003; 126: 276-284https://doi.org/10.1093/brain/awg045
        • Ramanathan S.
        • Reddel S.W.
        • Henderson A.
        • Parratt J.D.E.
        • Barnett M.
        • Gatt P.N.
        • Merheb V.
        • Kumaran R.-Y.A.
        • Pathmanandavel K.
        • Sinmaz N.
        • Ghadiri M.
        • Yiannikas C.
        • Vucic S.
        • Stewart G.
        • Bleasel A.F.
        • Booth D.
        • Fung V.S.C.
        • Dale R.C.
        • Brilot F.
        Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis.
        Neurol. Neuroimmunol. Neuroinflammation. 2014; 1https://doi.org/10.1212/NXI.0000000000000040
        • Huppke P.
        • Rostasy K.
        • Karenfort M.
        • Huppke B.
        • Seidl R.
        • Leiz S.
        • Reindl M.
        • Gärtner J.
        Acute disseminated encephalomyelitis followed by recurrent or monophasic optic neuritis in pediatric patients.
        Mult. Scler. J. 2012; 19: 941-946https://doi.org/10.1177/1352458512466317
        • Baumann Matthias
        • Hennes Eva-Maria
        • Schanda Kathrin
        • Karenfort Michael
        • Kornek Barbara
        • Seidl Rainer
        • Diepold Katharina
        • Lauffer Heinz
        • Marquardt Iris
        • Strautmanis Jurgis
        • Syrbe Steffen
        • Vieker Silvia
        • Höftberger Romana
        • Reindl Markus
        • Rostásy Kevin
        Children with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (MOG): extending the spectrum of MOG antibody positive diseases.
        Mult. Scler. J. 2016; 22: 1821-1829https://doi.org/10.1177/1352458516631038